After cutting deep into its medical device business early this year with a major restructuring, Johnson & Johnson (has offered a cheerier vision.

At the Barclays Global Healthcare Conference on March 17, it highlighted a consumer medical device focus, particularly in emerging markets, alongside six device areas of innovation that are expected to undergird growth in the segment for the conglomerate going forward.